Ebola patients may use Ibuprofen to beat airport detection – Expert

An Ebola patient being attended to
An Ebola patient being attended to

An infection control specialist, and president of Behavioural-based Improvement Solutions in Atlanta, Sean Kaufman, on Friday said people who contracted Ebola in West Africa could get through airport screenings and onto a plane.

Mr. Kaufman said that more must be done to identify infected travellers who could lie and take a lot of ibuprofen to beat the airport authorities.

“People can take ibuprofen to reduce their fever enough to pass screening, and why wouldn’t they?

“If it will get them on a plane so they can come to the United States and get effective treatment after they’re exposed to Ebola, wouldn’t you do that to save your life? ‘’ he said.

Reports said on Thursday that the first Ebola patient to be diagnosed in the United States had lied on a questionnaire at the Monrovia airport about his exposure to an Ebola patient.

He flew to Brussels and then Dulles airport outside Washington, D.C., before landing in Dallas on Sept. 20.

The traveller, Thomas Duncan, had no symptoms when he left Liberia, and fever scans there had shown a normal body temperature of 97.3 degrees Fahrenheit, U.S. health officials said.

He therefore could not have been identified through examination as carrying the Ebola virus.

His arrival and hospitalisation in Dallas have underscored how much U.S. authorities are relying on their counterparts in West African countries to screen passengers and contain the worst Ebola outbreak on record.

(Reuters/NAN)


NEVER MISS A THING AGAIN! Subscribe to our newsletter

* indicates required

DOWNLOAD THE PREMIUM TIMES MOBILE APP

Now available on

  Premium Times Android mobile applicationPremium Times iOS mobile applicationPremium Times blackberry mobile applicationPremium Times windows mobile application

TEXT AD: To place a text-based advert here. Call Willie - +2347088095401


All rights reserved. This material and any other material on this platform may not be reproduced, published, broadcast, written or distributed in full or in part, without written permission from PREMIUM TIMES.